| Delta Health Provider Based Clinics | |
|
1400 E Union St Greenville MS 38703-3246 | |
| (662) 378-3783 | |
| (662) 725-2289 |
| Full Name | Delta Health Provider Based Clinics |
|---|---|
| Speciality | Clinic/Center |
| Location | 1400 E Union St, Greenville, Mississippi |
| Authorized Official Name and Position | Iris Y. Stacker (CEO) |
| Authorized Official Contact | 6627252099 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Delta Health Provider Based Clinics Po Box 5247 Greenville MS 38704-5247 Ph: (662) 378-3783 | Delta Health Provider Based Clinics 1400 E Union St Greenville MS 38703-3246 Ph: (662) 378-3783 |
| NPI Number | 1083764542 |
|---|---|
| Provider Enumeration Date | 01/10/2007 |
| Last Update Date | 10/17/2022 |
| Medicare PECOS PAC ID | 0042208787 |
|---|---|
| Medicare Enrollment ID | O20040503000961 |
News Archive
Three projects from University of Colorado Cancer Center researchers have received grants from the Denver-based Michele Plachy-Rubin Fund for Pilot Grants in Brain Cancer Research. Receiving $40,000 each to fund their work around brain cancer are Sujatha Venkataraman, PhD; and the teams of Philip Reigan, PhD, and Michael Graner, PhD; and Natalie Serkova, PhD, and Nicholas Foreman, MD, MBChB.
Women who suffer from migraines may take at least some comfort in a recent, first-of-its-kind study that suggests a history of such headaches is associated with a significantly lower risk of breast cancer. Christopher I. Li, M.D., Ph.D., and colleagues at Fred Hutchinson Cancer Research Center report these findings in the November issue of Cancer Epidemiology, Biomarkers and Prevention.
In a society where obesity is increasingly recognized as a risk factor for disease, low- and no-calorie ingredients are logical choices for those wishing to manage their weight.
Inspire Pharmaceuticals, Inc. announced today the results from two Phase 2 clinical trials with AZASITE (azithromycin ophthalmic solution) 1% for the treatment of blepharitis. Inspire will conduct additional clinical work to continue pursuing a potential indication for treatment of anterior and posterior forms of blepharitis.
Alkermes plc and Elan Corporation, plc today announced the completion of the merger between Alkermes, Inc. and Elan Drug Technologies (EDT), the drug formulation and manufacturing business unit of Elan, following the approval of the merger by Alkermes, Inc. shareholders on Sept. 8, 2011.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083764542 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261Q00000X | Clinic/center | (* (Not Available)) | Primary |
| Provider Name | Maroun E Hayek |
|---|---|
| Provider Type | Practitioner - Hematology/oncology |
| Provider Identifiers | NPI Number: 1922072891 PECOS PAC ID: 4688714496 Enrollment ID: I20091229000299 |
News Archive
Three projects from University of Colorado Cancer Center researchers have received grants from the Denver-based Michele Plachy-Rubin Fund for Pilot Grants in Brain Cancer Research. Receiving $40,000 each to fund their work around brain cancer are Sujatha Venkataraman, PhD; and the teams of Philip Reigan, PhD, and Michael Graner, PhD; and Natalie Serkova, PhD, and Nicholas Foreman, MD, MBChB.
Women who suffer from migraines may take at least some comfort in a recent, first-of-its-kind study that suggests a history of such headaches is associated with a significantly lower risk of breast cancer. Christopher I. Li, M.D., Ph.D., and colleagues at Fred Hutchinson Cancer Research Center report these findings in the November issue of Cancer Epidemiology, Biomarkers and Prevention.
In a society where obesity is increasingly recognized as a risk factor for disease, low- and no-calorie ingredients are logical choices for those wishing to manage their weight.
Inspire Pharmaceuticals, Inc. announced today the results from two Phase 2 clinical trials with AZASITE (azithromycin ophthalmic solution) 1% for the treatment of blepharitis. Inspire will conduct additional clinical work to continue pursuing a potential indication for treatment of anterior and posterior forms of blepharitis.
Alkermes plc and Elan Corporation, plc today announced the completion of the merger between Alkermes, Inc. and Elan Drug Technologies (EDT), the drug formulation and manufacturing business unit of Elan, following the approval of the merger by Alkermes, Inc. shareholders on Sept. 8, 2011.
› Verified 5 days ago
| Provider Name | Mtanius A Sultani |
|---|---|
| Provider Type | Practitioner - Hematology/oncology |
| Provider Identifiers | NPI Number: 1972577930 PECOS PAC ID: 3779569934 Enrollment ID: I20111213000350 |
News Archive
Three projects from University of Colorado Cancer Center researchers have received grants from the Denver-based Michele Plachy-Rubin Fund for Pilot Grants in Brain Cancer Research. Receiving $40,000 each to fund their work around brain cancer are Sujatha Venkataraman, PhD; and the teams of Philip Reigan, PhD, and Michael Graner, PhD; and Natalie Serkova, PhD, and Nicholas Foreman, MD, MBChB.
Women who suffer from migraines may take at least some comfort in a recent, first-of-its-kind study that suggests a history of such headaches is associated with a significantly lower risk of breast cancer. Christopher I. Li, M.D., Ph.D., and colleagues at Fred Hutchinson Cancer Research Center report these findings in the November issue of Cancer Epidemiology, Biomarkers and Prevention.
In a society where obesity is increasingly recognized as a risk factor for disease, low- and no-calorie ingredients are logical choices for those wishing to manage their weight.
Inspire Pharmaceuticals, Inc. announced today the results from two Phase 2 clinical trials with AZASITE (azithromycin ophthalmic solution) 1% for the treatment of blepharitis. Inspire will conduct additional clinical work to continue pursuing a potential indication for treatment of anterior and posterior forms of blepharitis.
Alkermes plc and Elan Corporation, plc today announced the completion of the merger between Alkermes, Inc. and Elan Drug Technologies (EDT), the drug formulation and manufacturing business unit of Elan, following the approval of the merger by Alkermes, Inc. shareholders on Sept. 8, 2011.
› Verified 5 days ago
News Archive
Three projects from University of Colorado Cancer Center researchers have received grants from the Denver-based Michele Plachy-Rubin Fund for Pilot Grants in Brain Cancer Research. Receiving $40,000 each to fund their work around brain cancer are Sujatha Venkataraman, PhD; and the teams of Philip Reigan, PhD, and Michael Graner, PhD; and Natalie Serkova, PhD, and Nicholas Foreman, MD, MBChB.
Women who suffer from migraines may take at least some comfort in a recent, first-of-its-kind study that suggests a history of such headaches is associated with a significantly lower risk of breast cancer. Christopher I. Li, M.D., Ph.D., and colleagues at Fred Hutchinson Cancer Research Center report these findings in the November issue of Cancer Epidemiology, Biomarkers and Prevention.
In a society where obesity is increasingly recognized as a risk factor for disease, low- and no-calorie ingredients are logical choices for those wishing to manage their weight.
Inspire Pharmaceuticals, Inc. announced today the results from two Phase 2 clinical trials with AZASITE (azithromycin ophthalmic solution) 1% for the treatment of blepharitis. Inspire will conduct additional clinical work to continue pursuing a potential indication for treatment of anterior and posterior forms of blepharitis.
Alkermes plc and Elan Corporation, plc today announced the completion of the merger between Alkermes, Inc. and Elan Drug Technologies (EDT), the drug formulation and manufacturing business unit of Elan, following the approval of the merger by Alkermes, Inc. shareholders on Sept. 8, 2011.
› Verified 5 days ago
The Greenville Clinic Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1502 S Colorado St, Greenville, MS 38703 Phone: 662-332-9872 Fax: 662-332-9878 | |
Magnolia Family Medical Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1660 S Colorado St, Greenville, MS 38703 Phone: 662-332-2077 Fax: 662-332-0790 | |
Infusions,llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1313 E Union St, Greenville, MS 38703 Phone: 662-332-1153 Fax: 662-332-1157 | |
Dominick Trinca, M.d. Pa Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1440 Highway 1 S, Greenville, MS 38701 Phone: 662-820-4363 | |
Np Healthcare Clinic Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 559a Highway 1 N, Greenville, MS 38701 Phone: 662-702-5159 Fax: 662-702-5164 | |
F H Faith Medical Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1508 Hospital St, Greenville, MS 38703 Phone: 662-332-8848 Fax: 662-332-8854 |